Inventor · disambiguated record
Josef Messinger
Also filed as: MESSINGER JOSEF
15 granted patents·7 pending applications·244 citations·filing 1996–2021
91Inventor score
Top patents by PatentIndex Score
22 records- 0191US5677297ABenzazepine-, benzoxazepine- and benzothiazepine-n-acetic acid derivatives, process for their preparation and pharmaceutical compositions containing themSOLVAY PHARM GMBH·Filed 1996·Granted Oct 14, 1997·125 cites·14 claims
- 0287US8546392B217Beta-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of hormone-related diseasesHARTMANN ROLF·Filed 2008·Granted Oct 1, 2013·37 cites·8 claims
- 0375US6602880B23-phenyl-3,7-diazabicyclo[3.3.1] nonane compounds, process for preparing them, pharmaceutical compositions containing them and use thereof to inhibit cardiac arrhythmiaSOLVAY PHARM GMBH·Filed 2002·Granted Aug 5, 2003·7 cites·8 claims
- 0475US6197198B1Method and device for parallel chromatographySOLVAY PHARM GMBH·Filed 1998·Granted Mar 6, 2001·63 cites·16 claims
- 0574US7410962B2Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing themSOLVAY PHARM GMBH·Filed 2007·Granted Aug 12, 2008·2 cites·11 claims
- 0673US8030298B217β-HSD1 and STS inhibitorsABBOTT PRODUCTS GMBH·Filed 2006·Granted Oct 4, 2011·3 cites·23 claims
- 0773US7427611B2Amidomethyl-substituted 1-(carboxyalkyl)-cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing themSOLVAY PHARM GMBH·Filed 2006·Granted Sep 23, 2008·2 cites·11 claims
- 0871US7262184B2Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing themSOLVAY PHARM GMBH·Filed 2004·Granted Aug 28, 2007·2 cites·14 claims
- 0970US8288367B2Substituted estratriene derivatives as 17BETA HSD inhibitorsMESSINGER JOSEF·Filed 2007·Granted Oct 16, 2012·2 cites·34 claims
- 1069US2022047540A1Catechol o-methyltransferase activity inhibiting compoundsORION CORP·Filed 2021·Application pending·0 cites
- 1165US2020352898A1Catechol o-methyltransferase activity inhibiting compoundsORION CORP·Filed 2020·Application pending·0 cites
- 1259US7524853B2Compounds and their use in therapySOLVAY PHARM BV·Filed 2004·Granted Apr 28, 2009·1 cites·40 claims
- 1359US2020009103A1Catechol o-methyltransferase activity inhibiting compoundsORION CORP·Filed 2019·Application pending·0 cites
- 1458US2019029990A1Catechol o-methyltransferase activity inhibiting compoundsORION CORP·Filed 2018·Application pending·0 cites
- 1555US9458128B2Catechol O-methyltransferase activity inhibiting compoundsORION CORP·Filed 2013·Granted Oct 4, 2016·0 cites·52 claims
- 1653US7452875B2Amidomethyl-substituted 1-(carboxyalkyl) cyclopentyl-carbonylamino-benzazepine-N-acetic acid compounds, process and intermediate products for their preparation and pharmaceutical compositions containing themSOLVAY PHARM GMBH·Filed 2007·Granted Nov 18, 2008·0 cites·11 claims
- 1753US2017165219A1Catechol o-methyltransferase activity inhibiting compoundsORION CORP·Filed 2016·Application pending·0 cites
- 1845US2008249075A1C11 Modified Retrosteroids as Progesterone Receptor Modulator CompoundsSOLVAY PHARM GMBH·Filed 2008·Application pending·0 cites
- 1943US2007212751A1Microbial method for the 11beta hydroxylation of 9beta, 10alpha-steriodsSOLVAY PHARM GMBH·Filed 2007·Application pending·0 cites
- 2040US8435973B217-beta HSD1 and STS inhibitorsMESSINGER JOSEF·Filed 2010·Granted May 7, 2013·0 cites·21 claims
- 2140US8080540B2Therapeutically active triazoles and their useMESSINGER JOSEF·Filed 2007·Granted Dec 20, 2011·0 cites·22 claims
- 2237US8088758B217β-hydroxysteroid dehydrogenase type I inhibitorsMESSINGER JOSEF·Filed 2004·Granted Jan 3, 2012·0 cites·41 claims
Join the waitlist — get patent alerts
Get an alert when Josef Messinger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →